Cargando…
Histamine 2 receptor antagonists do not improve the outcomes of hospitalized COVID-19 patients
INTRODUCTION: Some observational studies have demonstrated the benefit of famotidine in COVID-19-infected individuals. The preference of using an H(2) receptor antagonist (H(2)RA) over proton pump inhibitors (PPI) during the COVID-19 pandemic has been questioned by clinicians. AIM: To compare the ou...
Autores principales: | Amjad, Waseem, Kamal, Faisal, Malik, Adnan, Singh, Ritu, Mahmood, Sultan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165339/ https://www.ncbi.nlm.nih.gov/pubmed/35664030 http://dx.doi.org/10.5114/pg.2021.107799 |
Ejemplares similares
-
10 IMPACT OF CHRONIC LIVER DISEASE ON THE COVID-19 HOSPITAL ADMITTED PATIENTS
por: Amjad, Waseem, et al.
Publicado: (2021) -
Cetirizine a histamine H1 receptor antagonist improves viral myocarditis
por: Matsumori, Akira, et al.
Publicado: (2010) -
Effects of Olopatadine Hydrochloride, a Histamine H(1) Receptor Antagonist, on Histamine-Induced Skin Responses
por: Hashimoto, Takashi, et al.
Publicado: (2010) -
In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2020) -
Effects of histamine and various histamine receptor antagonists on gene expression profiles of macrophages during compressive strain
por: Schröder, Agnes, et al.
Publicado: (2021)